[177Lu]-DOTA0-Tyr3-octreotate: A potential targeted radiotherapeutic for the treatment of Medulloblastoma

Journal Article

Medulloblastoma, the most common pediatric brain tumor, is difficult to treat because conventional therapeutic approaches result in significant toxicity to normal central nervous system tissues, compromising quality of life. Given the fact that medulloblastomas express the somatostatin subtype 2 receptor, [ 177 Lu-DOTA 0 ,Tyr 3 ]octreotate ([ 177 Lu]DOTA- TATE) could be a potentially useful targeted radiotherapeutic for the treatment of this malignancy. The current study was undertaken to evaluate this possibility in preclinical models of D341 MED human medulloblastoma by comparing the properties of [ 177 Lu]DOTA-TATE to those of glucose-[ 125 I-Tyr 3 ]-octreotate ([ 125 I]Gluc-TOCA), a radiopeptide previously shown to target this cell line. In vitro assays indicated that both labeled peptides exhibited similar cell-associated and in- ternalized radioactivity after a 30-min incubation at 37 o C; however, at the end of the 4 h incubation period, the internal- ized radioactivity for [ 177 Lu]DOTA-TATE (6.22 ± 0.75%) was nearly twice that for [ 125 I]Gluc-TOCA (3.16 ± 0.27%), with similar differences seen in total cell-associated radioactivity levels. Consistent with the results from the internaliza- tion assays, results from paired-label tissue distribution studies in athymic mice with subcutaneous D341 MED medul- loblastoma xenografts showed a similar degree of tumor accumulation for [ 177 Lu]DOTA-TATE and [ 125 I]Gluc-TOCA at early time points but by 24 h, a more than 5-fold advantage was observed for the 177 Lu-labeled peptide. Tumor-to-normal tissue ratios generally were more favorable for [ 177 Lu]DOTA-TATE at all time points, due in part to its lower accumula- tion in normal tissues except kidneys. Taken together, these results suggest that [ 177 Lu]DOTA-TATE warrants further in- vestigation as a targeted radiotherapeutic for medulloblastoma treatment. ©2010 Bentham Science Publishers Ltd.

Full Text

Duke Authors

Cited Authors

  • Vaidyanathan, G; Affleck, DJ; Zhao, XG; Keir, ST; Zalutsky, MR

Published Date

  • July 12, 2010

Published In

Volume / Issue

  • 3 / 1

Start / End Page

  • 29 - 36

International Standard Serial Number (ISSN)

  • 1874-4710

Digital Object Identifier (DOI)

  • 10.2174/1874471011003010029

Citation Source

  • Scopus